Search results
Showing 1426 to 1440 of 1517 results for patients and public
In development Reference number: GID-TA11663 Expected publication date: TBC
In development Reference number: GID-TA11511 Expected publication date: TBC
This guideline covers the period before, during and after a young person moves from children's to adults' services. It aims to help young people and their carers have a better experience of transition by improving the way it’s planned and carried out. It covers both health and social care.
Filgotinib for treating moderately to severely active Crohn's disease [ID6236]
Discontinued Reference number: GID-TA11244
Pembrolizumab with lenvatinib for previously treated metastatic colorectal cancer [ID5112]
Discontinued Reference number: GID-TA11020
Discontinued Reference number: GID-TA11204
In development Reference number: GID-TA11401 Expected publication date: TBC
Empagliflozin for preventing cardiovascular events after acute myocardial infarction [ID6240]
In development Reference number: GID-TA11265 Expected publication date: TBC
In development Reference number: GID-TA11021 Expected publication date: TBC
In development Reference number: GID-TA11089 Expected publication date: TBC
Venetoclax with azacitidine for untreated high-risk myelodysplastic syndromes [ID6314]
In development Reference number: GID-TA11368 Expected publication date: TBC
Botulinum toxin type A for preventing episodic migraine [ID6450]
In development Reference number: GID-TA11505 Expected publication date: TBC
In development Reference number: GID-TA11299 Expected publication date: TBC
Oral paclitaxel with encequidar for treating advanced breast cancer [ID5111]
In development Reference number: GID-TA11022 Expected publication date: TBC
In development Reference number: GID-TA11278 Expected publication date: TBC